Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|July 2, 2014
Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signalsLaura Gatti, Alexandra Sevko, Michelandrea De Cesare, et al.
Tumori|June 24, 2026
Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patientsAndrea Vingiani, Alberta Piccolo, Adele Busico, et al.
Clinical Breast Cancer|August 29, 2024
Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the BreastChiara M Ciniselli, Paolo Verderio, Paolo Baili, et al.
Frontiers in Oncology|February 17, 2023
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTOSerena Di Cosimo, Chiara M Ciniselli, Sara Pizzamiglio, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 29, 2024
Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary interventionOscar Illescas, Giulio Ferrero, Antonino Belfiore, et al.
Cancers|November 9, 2024
From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast CancerAlice Bernasconi, Alessio Zanga, Peter J F Lucas, et al.
Cancer Medicine|December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO studySara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 23, 2025
Molecular targeting of the deubiquitinase USP14 to circumvent cisplatin resistance in ovarian carcinoma and identification of novel inhibitorsCristina Corno, Debora Russo, Francesco Pignotti, et al.
Pageof 2